Cardiac complications up after SARS-CoV-2 infection versus vaccines
Apr 06, 2022
“[T]he risks for these complications were higher after infection than after vaccination among males and females in all age groups,” the authors write.
Vaccination offers extra protection after SARS-CoV-2 infection
Apr 06, 2022
Two studies show additional protection against reinfection and COVID-19-linked hospitalization with vaccination.
FDA panel meets to craft future vaccine strategy
Apr 06, 2022
No official vote is planned, and no specific vaccine products will be discussed.
As second COVID-19 booster dose is approved, senior living calls for help
By
Kimberly Bonvissuto
Mar 30, 2022
As public health officials brace for a potential surge in coronavirus cases due to the BA.2 variant, the federal government on Tuesday approved a second COVID-19 booster dose for higher-risk individuals.
‘Natural immunity’ now satisfies employer vaccine mandates in Utah
By
Kimberly Bonvissuto
Mar 30, 2022
Natural immunity to COVID-19 infection could allow Utah senior living and other workers to sidestep workplace vaccine mandates.
Biden administration to offer second COVID-19 boosters to those 50+
Mar 28, 2022
Although a second booster for older adults will be offered, federal health officials will not go so far as to recommend it.
Fourth mRNA COVID-19 vaccine immunogenic, safe
Mar 24, 2022
Vaccine efficacy 30% for BNT162b2(Pfizer) and 11 percent for mRNA-1273 (Moderna) against any SARS-CoV-2 infection.
Effectiveness of Ad26.COV2.S vaccine stable for six months
Mar 22, 2022
A single dose of the Johnson & Johnson vaccine was 74% and 81% effective for preventing COVID-19 infection and hospitalizations, respectively, in the U.S. before and during delta variant surge.
No myocarditis recurrence after SARS-CoV-2 vaccination
Mar 22, 2022
No cases of myocarditis were seen after vaccination in small study with 55 patients with a history of myocarditis who were vaccinated.
Risk for shoulder conditions small after vaccination in deltoid muscle
Mar 21, 2022
The incidence of shoulder conditions per 10,000 vaccinations was 1.22 for adults (age 18 years or older) and 0.05 for children (age 3 to 17 years).